Zobrazeno 1 - 4
of 4
pro vyhledávání: '"I. P. Matyukhov"'
Publikováno v:
Медицинский совет, Vol 0, Iss 2, Pp 28-32 (2015)
Erectile dysfunction (ED) means inability to achieve and maintain an erection long enough to engage in sexual intercourse [1, 2]. Erectile dysfunction is an obvious cause of a decline in the overall quality of life [9]. For the implementation of erec
Externí odkaz:
https://doaj.org/article/32ace585234a4f2bb8f39e6bba0835d7
Autor:
N D Akhvlediani, I P Matyukhov
Publikováno v:
Urologiia. :142-146
Sildenafil is the first phosphodiesterase type 5 inhibitor (PDE-5), used in the management of erectile dysfunction (ED). The effectiveness and safety of the original drug have been studied most extensively among ED medications. Sildenafil has been su
Autor:
I P Matyukhov, N D Akhvlediani
Publikováno v:
Urologiia. :106-110
The aim of the study is to assess the evidence on the efficacy and safety of dapoxetine in premature ejaculation (PE). The analysis includes results of randomized placebo-controlled trials, integrative reviews and one meta-analysis on the clinical ef
Autor:
N D, Akhvlediani, I P, Matyukhov
Publikováno v:
Urologiia (Moscow, Russia : 1999). (5)
To compare the effectiveness of the phosphodiesterase type 5 inhibitor (PDE-5i) tadalafil alone and in combination with a biologically active dietary supplement (BADS) NeyroDoz, containing the precursors of serotonin in patients with erectile dysfunc